tiprankstipranks
Trending News
More News >
Takara Bio Inc. (JP:4974)
:4974
Japanese Market

Takara Bio Inc. (4974) Income Statement

Compare
2 Followers

Takara Bio Inc. Income Statement

Last quarter (Q1 2025), Takara Bio Inc.'s total revenue was ¥9.27B, an increase of 9.10% from the same quarter last year. In Q1, Takara Bio Inc.'s net income was ¥-1.51B. See Takara Bio Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 45.04B¥ 43.51B¥ 78.14B¥ 67.70B¥ 46.09B
Gross Profit
¥ 26.07B¥ 26.91B¥ 44.77B¥ 49.21B¥ 31.87B
Operating Expenses
¥ 23.80B¥ 23.91B¥ 24.22B¥ 20.31B¥ 17.92B
Depreciation and Amortization
¥ 4.48B¥ 5.02B¥ 4.74B¥ 4.15B¥ 3.79B
EBITDA
¥ 6.50B¥ 7.90B¥ 25.98B¥ 31.70B¥ 17.36B
Operating Income
¥ 2.26B¥ 3.00B¥ 20.54B¥ 28.90B¥ 13.95B
Other Income/Expenses
¥ -266.00M¥ -150.00M¥ 683.00M¥ -1.37B¥ -400.00M
Pretax Income
¥ 2.00B¥ 2.85B¥ 21.22B¥ 27.53B¥ 13.55B
Net Income
¥ 1.04B¥ 1.48B¥ 16.01B¥ 19.85B¥ 9.55B
Per Share Metrics
Basic EPS
¥ 8.65¥ 12.29¥ 132.97¥ 164.84¥ 79.28
Diluted EPS
¥ 8.65¥ 12.29¥ 132.97¥ 164.84¥ 79.28
Weighted Average Shares Outstanding
120.42M 120.42M 120.42M 120.42M 120.42M
Weighted Average Shares Outstanding (Diluted)
120.42M 120.42M 120.42M 120.42M 120.42M
Currency in JPY

Takara Bio Inc. Earnings and Revenue History